---
document_datetime: 2025-11-11 14:33:37
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/slenyto-epar-all-authorised-presentations_en.pdf
document_name: slenyto-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8736496
conversion_datetime: 2025-12-15 00:03:26.877744
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU (MA) Number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging    | Pack size   |
|------------------|-------------------|------------|--------------------------|---------------------------|------------------------|-------------|
| EU/1/18/1318/001 | Slenyto           | 1 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 60 tablets  |
| EU/1/18/1318/003 | Slenyto           | 5 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 30 tablets  |
| EU/1/18/1318/005 | Slenyto           | 1 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 30 tablets  |
| EU/1/18/1318/006 | Slenyto           | 5 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 100 tablets |